News
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.
6d
Africanews on MSNTrump Administration's funding cuts jeopardize HIV research in South AfricaAt the University of the Witwatersrand, scientists are developing HIV vaccines that could help change the course of the ...
Both Mashatile and Motsoaledi have repeatedly lamented, correctly, the severe reliance of our health system on external ...
3d
allAfrica.com on MSNSA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snagSA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
5d
Face2FaceAfrica on MSN“Stop all work” – U.S. aid cuts derail HIV vaccine trials in South AfricaJust days before South African scientists were set to launch clinical trials of a promising HIV vaccine, their progress was ...
Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world ...
Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results